These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
126 related articles for article (PubMed ID: 15243398)
21. Pioglitazone-induced acute rhabdomyolysis. Slim R; Ben Salem C; Zamy M; Biour M Diabetes Care; 2009 Jul; 32(7):e84. PubMed ID: 19564463 [No Abstract] [Full Text] [Related]
22. The value equation for rosiglitazone and pioglitazone in older persons. Zarowitz BJ Geriatr Nurs; 2008; 29(1):9-11. PubMed ID: 18267172 [No Abstract] [Full Text] [Related]
23. Hepatocellular injury in a patient receiving pioglitazone. Maeda K Ann Intern Med; 2001 Aug; 135(4):306. PubMed ID: 11511159 [No Abstract] [Full Text] [Related]
24. [Uncertainly after publications on glitazones. Elevated myocardial infarction risk is not a class effect]. Erdmann E; Scherbaum WA MMW Fortschr Med; 2007 Dec; 149(49-50):49-50. PubMed ID: 18236983 [No Abstract] [Full Text] [Related]
25. [A case of drug induced liver injury related pioglitazone]. Hisamochi A; Kumashiro R; Koga Y; Tanaka E; Ide T; Hino T; Murashima S; Ogata K; Kuwahara R; Koga H; Shishido S; Ueno T; Sata M; Eguchi T Nihon Shokakibyo Gakkai Zasshi; 2003 Mar; 100(3):333-6. PubMed ID: 12696176 [No Abstract] [Full Text] [Related]
26. Pioglitazone and lung cancer risk in Taiwanese patients with type 2 diabetes. Tseng CH Diabetes Metab; 2018 Feb; 44(1):77-79. PubMed ID: 28684163 [No Abstract] [Full Text] [Related]
27. Thiazolidinediones for type 2 diabetes. New agents reduce insulin resistance but need long term clinical trials. Krentz AJ; Bailey CJ; Melander A BMJ; 2000 Jul; 321(7256):252-3. PubMed ID: 10915108 [No Abstract] [Full Text] [Related]
28. Comment: analyses using time-dependent pioglitazone usage in Cox models may lead to wrong conclusions about its association with cancer. Yang X; Chan JC Diabetes Care; 2011 Aug; 34(8):e136; author reply 137. PubMed ID: 21788639 [No Abstract] [Full Text] [Related]
29. The "glitazones": rosiglitazone and pioglitazone. Papoushek C J Obstet Gynaecol Can; 2003 Oct; 25(10):853-7. PubMed ID: 14532954 [TBL] [Abstract][Full Text] [Related]
30. Do thiazolidinediones still have a role in treatment of type 2 diabetes mellitus? Consoli A; Formoso G Diabetes Obes Metab; 2013 Nov; 15(11):967-77. PubMed ID: 23522285 [TBL] [Abstract][Full Text] [Related]
31. Pioglitazone-induced heart failure in a patient with restrictive cardiomyopathy and metabolic myopathy. Finsterer J; Stöllberger C Clin Res Cardiol; 2009 Apr; 98(4):271-4. PubMed ID: 19205775 [No Abstract] [Full Text] [Related]
32. Pioglitazone for diabetes prevention. Goldstein MR; Mascitelli L N Engl J Med; 2011 Jul; 365(2):183; author reply 183-4. PubMed ID: 21751925 [No Abstract] [Full Text] [Related]
33. "Did this drug cause my patient's hepatitis?" and related questions. Nierenberg DW Ann Intern Med; 2002 Mar; 136(6):480-3. PubMed ID: 11900502 [No Abstract] [Full Text] [Related]
34. The Effects of Pioglitazone on Bone Formation and Resorption Markers in Type 2 Diabetes Mellitus. Mori H; Okada Y; Tanaka Y Intern Med; 2017; 56(11):1301-1306. PubMed ID: 28566590 [TBL] [Abstract][Full Text] [Related]
35. Summary for patients. Liver damage in a person taking the diabetes drug pioglitazone. Ann Intern Med; 2002 Mar; 136(6):I65. PubMed ID: 11900516 [No Abstract] [Full Text] [Related]
36. [Is Pioglitazone blessing or curse?]. Barthel A Dtsch Med Wochenschr; 2016 Aug; 141(17):1207. PubMed ID: 27557061 [No Abstract] [Full Text] [Related]
37. Hypoglycaemia with pioglitazone: analysis of data from the Prescription-Event Monitoring study. Vlckova V; Cornelius V; Kasliwal R; Wilton L; Shakir S J Eval Clin Pract; 2010 Dec; 16(6):1124-8. PubMed ID: 21176002 [TBL] [Abstract][Full Text] [Related]
38. [Pioglitazone in evaluation by IQWiG (Institute for Quality and Cost Effectiveness in Public Health)--tunnel vision instead of broad view]. MMW Fortschr Med; 2008 Aug; 150(32-35):56-7. PubMed ID: 19009700 [No Abstract] [Full Text] [Related]
39. Reversible mitral and aortic regurgitation due to pioglitazone. Kota SK; Tripathy PR; Kota SK; Jammula S; Panda S; Modi KD Endocr Pract; 2012; 18(2):e32-6. PubMed ID: 22440995 [TBL] [Abstract][Full Text] [Related]